6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets Effective 10/06/2025-10/05/2026

Award Notice Posted

Solicitation number
36E79725R0035
Agency
Awarded
to Avkare LLC
Set-aside
No set-aside

Opportunity facts

Contract number
36E79725D0046 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center has awarded contract 36E79725D0046 to AVKARE LLC for the procurement of Emtricitabine/Tenofovir Disoproxil Fumarate Tablets with a contract value of $9,977,967.85. The award was made on June 27, 2025, and the contract period is effective from October 6, 2025 through October 5, 2026, representing a one-year pharmaceutical supply agreement. These tablets are antiretroviral medications commonly used in HIV treatment and prevention protocols, indicating the VA's ongoing commitment to providing essential pharmaceutical services to veterans requiring these specialized medications.

Notice text

Awarded contract 36E79725D0046 to AVKARE LLC for 9977967.85 on 2025-06-27.

Files

File Type Posted
36E79725D0046_1.docx DOCX document

Notice history

Notice Type Posted
This notice Award Award Notice
6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets Latest solicitation Solicitation
6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors